A real-world disproportionality analysis of FDA adverse event reporting system events for ibuprofen.

Yi-Kuan Du Zhuoming Guo Bijun Xu Yujia Yang Mianda Hu Yanghui Hu Yurong Yang Mengting Zhang Zhenjie Wang Xiaochun Guo Yixing Huang Jinfeng Zhu Weichui Zhang Chun Yang

Published in: Expert opinion on drug safety (2024)

The study explores the important and valuable potential AEs and ADRs of ibuprofen at the SOC and PT levels, respectively. To provide a reference for decision-making for ibuprofen to promote rational clinical dosing.

Keyphrases

decision making
postoperative pain
adverse drug
emergency department